Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 9, 1997, Pages 711-718

  Hu, Wei ^a   Mitchell, Michele Follen ^a,b   Boiko, Iouri V ^a   Linares, Adriana ^a   Kim, Heung G ^a   Malpica, Anais ^a   Tortolero Luna, Guillermo ^a   Hittelman, Walter N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPITOPE; MONOCLONAL ANTIBODY;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MITOSIS; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MITOTIC INDEX; PROTEIN-SERINE-THREONINE KINASES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0030799230     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of 18 major cancers. Int. J. Cancer, 54: 595-606, 1993.
2. Mitchell, M. F., Hittelman, W. N., Lotan, R., Nishioka, K., Tortolero-Luna, G., Richards-Kortum, R., Wharton, J. T., and Hong, W. K. Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer (Phila.), 76 (Suppl.): 1956-1977, 1995.
3. Mitchell, M. F., Hittelman, W. N., and Hong, W. K. The natural history of cervical intraepithelial neoplasia: an argument for intermediate end point biomarkers. Cancer Epidemiol., Biomarkers & Prev., 3: 619-626, 1994.
4. Szarka, C. E., Granna, G., and Engstrom, P. F. Chemoprevention of cancer. Curr. Probl. Cancer, 18: 13-15, 1994.
5. Coppleson, M., Atkinson, K. H., and Dalrymple, J. C. Cervical squamous and glandular intraepithelial neoplasia: clinical features and review of management. In: M. Coppleson, J. Monaghan, C. P. Morrow, and M. N. Tattersall (eds.), Gynecologic Oncology: Fundamental Principles and Clinical Practice, pp. 571-573. New York: Churchill Livingstone, 1992.
6. Nakano, T., and Oka, K. Differential values of Ki-67 index and mitotic index of proliferating cell populations. Cancer (Phila.), 72: 2401-2408, 1993.
7. Kujari, H. P., Collan, Y. I., and Atkin, N. B. Use of the mitotic counts for the prognosis and grading of breast cancer. Pathol. Res. Pract., 190: 593-599, 1994.
8. Lipponen, P. K., and Eskdinen, M. J. Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer. Eur. Urol., 18: 258-262, 1990.
9. Davis, F. M., Tsao, T. Y., Fowler, S. K., and Rao, P. N. Monoclonal antibody to mitotic cells. Proc. Natl. Acad. Sci. USA, 80: 2926-2930, 1983.
10. Kuang, J., Zhao, J. Y., Wright, D. A., Saunders, G. F., and Rao, P. N. Mitosis-specific monoclonal antibody 2 inhibits Xenopus oocyte maturation and depletes maturation-promoting activity. Proc. Natl. Acad. Sci. USA, 86: 4982-4986, 1989.
11. Kuang, J., Penkala, J. E., Wright, D. A., Saunders, G. F., and Rao, P. N. A novel M-phase-specific HI kinase recognized by the mitosis-specific monoclonal antibody MPM-2. Dev. Biol., 144: 54-64, 1991.
12. Kuang, J., and Ashorn, C. L. At least two kinases phosphorylate the MPM-2 epitope during Xenoptis oocyte maturation. J. Cell Biol., 123: 859-868, 1993.
13. Taagepera, S., Rao, P. N., Drake, F. H., and Gorbsky, G. J. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl. Acad. Sci. USA, 90: 8407-8411, 1993.
14. Kuang, J., Ashorn, C. L., Gonzalcz-kuyvenhoren, M., and Penkala, J. E. Cdc25 is one of the MPM-2 antigens involved in the activation of maturation promoting factor. Mol. Biol. Cell, 5: 135-145, 1994.
15. Yu, C. W., Woods, A. L., and Levison, D. A. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem. J., 24: 121-131, 1992.
16. Al-Salch, W., Delvenne, P., Greimers, R., Fridman, V., Doyen, J., and Boniver, J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Am. J. Clin. Pathol, 104: 154-160, 1995.
17. Hall, P. A., Levison, D. A., and Lane, D. P. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin section: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol., 162: 285-294, 1990.
18. Shin, D. M., Hittelman, W. N., and Hong, W. K. Biomarkers in upper aerodigestive tract tumorieenesis: a review. Cancer Epidemiol., Biomarkers & Prev., 3: 697-709, 1994.
19. Felix, H. S., and Butz, K. Cellular control of human papillomavirus. Mol. Carcinog., 10: 134-141, 1994.